Your browser doesn't support javascript.
loading
Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea.
Cho, Minah; Woo, Yu Ri; Cho, Sang Hyun; Lee, Jeong Deuk; Kim, Hei Sung.
Afiliação
  • Cho M; Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Woo YR; Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Cho SH; Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee JD; Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim HS; Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. hazelkimhoho@gmail.com.
Acta Derm Venereol ; 103: adv18392, 2023 Dec 11.
Article em En | MEDLINE | ID: mdl-38078688
ABSTRACT
Metformin is a widely used drug for treatment of diabetes mellitus, due to its safety and efficacy. In addition to its role as an antidiabetic drug, numerous beneficial effects of metformin have enabled its use in various diseases. Considering the anti-androgenic, anti-angiogenic, anti-fibrotic and antioxidant properties of metformin, it may have the potential to improve chronic inflammatory skin diseases. However, further evidence is needed to confirm the efficacy of metformin in dermatological conditions, This review focuses on exploring the therapeutic targets of metformin in acne vulgaris, hidradenitis suppurativa and rosacea, by studying their pathogeneses.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa / Acne Vulgar / Rosácea / Metformina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa / Acne Vulgar / Rosácea / Metformina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article